Melanoma, the deadliest form of skin cancer, is diagnosed in more than 130,000 people globally every year. Now, work is being done on a tool to help in its early detection: a simple, compact laser probe that can distinguish between harmless moles and cancerous ones – in a matter of seconds.
“With skin cancer, there’s a saying that if you can spot it you can stop it – and that’s exactly what this probe is designed to do,” said researcher Daniel Louie, a PhD student who constructed the device as part of his studies in biomedical engineering at the University of British Columbia. “We set out to develop this technology using inexpensive materials, so the final device would be easy to manufacture and widely used as a preliminary screening tool for skin cancer.”
The probe works on the principle that light waves change as they pass through objects. The researchers aimed a laser into skin tissue from volunteer patients and studied the changes that occurred to this light beam.
“Because cancer cells are denser, larger and more irregularly shaped than normal cells, they cause distinctive scattering in the light waves as they pass through,” said Louie. “We were able to invent a novel way to interpret these patterns instantaneously.”
Imaging devices to assist cancer detection are not new, but this optical probe can extract measurements without needing expensive lenses or cameras, and it can provide a more easily interpreted numerical result like those of a thermometer. Although the probe’s components cost only a few hundred dollars total, it is not envisioned to be a consumer product.
“A cancer screening tool should be administered by a trained health care professional who would know where the patient needs to go afterwards,” said Tim Lee, an associate professor of skin science and dermatology at UBC and a senior scientist at both BC Cancer and the Vancouver Coastal Health Research Institute, who supervised the work. He believes the device would be a good future addition to standard cancer screening methods, but not a replacement.
Noting that about 7,200 new cases of melanoma are reported every year in Canada, Lee believes the probe can promote early detection of this cancer.
“We have so few dermatologists relative to the growing number of skin cancers that are occurring,” said Lee. “If we can develop a device that can be integrated easily into other parts of the health care system, we can simplify the screening process and potentially save hundreds if not thousands of lives.”
The study, described in the Journal of Biomedical Optics, involved 69 lesions from 47 volunteer patients at the Vancouver General Hospital Skin Care Centre and is a joint project among UBC, BC Cancer and VCHRI. For their next steps, the researchers hope to eventually achieve Health Canada certification and approval before being able to offer this testing through health professionals. This will require further refinement of their technology and additional clinical testing in more patients.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Adjuvant Therapy for Melanoma: Understanding Your Treatment Options on March 7, 2019 at 2:45 pm
When you think of treatment for skin cancer, you reasonably imagine a patient just undergoing surgical excision—cutting out the tumor from the skin. This is the first treatment people with skin cancer ... […]
- Handheld Melanoma Sensor Checks Suspect Lesions for Polarization Properties on March 7, 2019 at 1:08 pm
Melanoma is usually a readily accessible cancer, being on the skin and in full view, but it can be hard to differentiate from benign moles. Researchers at the University of British Columbia have devel... […]
- A New Dosing Regimen for Nivolumab Plus Ipilimumab in Advanced Melanoma on March 7, 2019 at 10:11 am
Among advanced melanoma patients in the CheckMate 511 phase IIIb/IV trial, raising the nivolumab dose to 3 mg/kg and lowering the ipilimumab dose to 1 mg/kg leads to a better safety profile without co... […]
- First-in-human clinical study of novel technique to diagnose malignant melanoma via thermal conductivity measurements on March 7, 2019 at 8:10 am
Melanoma is an aggressive skin cancer that originates from melanocytes and, especially in the case of early-stage melanoma, is distributed adjacent to the epidermis and superficial dermis. Although ea... […]
- Lowering the Risk of Melanoma Recurrence: Is It Possible? on March 7, 2019 at 8:05 am
Most types of skin cancer are unlikely to spread (or metastasize) to other parts of the body, and tumors can be removed by a surgical excision relatively easily. However, melanoma is another story. Me... […]
- Melanoma Patient: Be Alert To Cancer Symptoms on March 6, 2019 at 8:30 pm
KwaZulu-Natal resident Hodgson, was diagnosed with melanoma in 2018, after experiencing a series of ‘niggling’ and seemingly minor health complaints for several months. “I was eating clean, getting a ... […]
- Non-Melanoma Skin Cancer Treatment Market forecast 2019-2023 explored in latest research on March 6, 2019 at 1:33 pm
2019 Study on Global Non-Melanoma Skin Cancer Treatment Market report include all basic information related to the global Industry and forecast till 2025. The objectives of this study are to define, s... […]
- Low-cost 'cancer probe' could spot deadly melanoma early on March 6, 2019 at 1:00 pm
Work is being done on a tool to help in the early detection of melanoma: a simple, compact laser probe that can distinguish between harmless moles and cancerous ones -- in a matter of seconds. Melanom... […]
- How Immunotherapy Is Improving Treatment for Melanoma on March 6, 2019 at 8:08 am
One reason cancer has historically been so difficult to treat is that cancer cells can basically hide from the body’s immune system. Normally, your immune system helps recognize foreign threats within ... […]
- Publication of Independent Prospective, Multicenter Study Reinforces Accuracy of DecisionDx-Melanoma Test Recurrence Risk Prediction on March 6, 2019 at 4:59 am
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Mar 6, 2019--Castle Biosciences, Inc., a skin cancer diagnostics company providing personalized genomic information to improve cancer management decisions, today a... […]
via Bing News